 |
|
Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer
Emre Günakan, Yusuf Aytaç Tohma, Latife Atasoy Karakaş, Hüseyin Akıllı, Asuman Nihan Haberal, Ali Ayhan
Obstet Gynecol Sci. 2020;63(4):464-469. Published online 2020 Jun 19 DOI: https://doi.org/10.5468/ogs.19204
|
|
Citations to this article as recorded by
 MRI Appearances of Stage IA Ovarian Carcinoma
Li Wen Cui, Zhi Yong Shen
Current Medical Imaging Formerly Current Medical Imaging Reviews.2023;[Epub] CrossRef Immunohistochemical expression of Forkhead Box (Fox) A1 and P53 in epithelial ovarian cancer
Elnashar Afaf T, Youssef Esraa M
Clinical Journal of Obstetrics and Gynecology.2022; 5(2): 061. CrossRef Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma
Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat
Obstetrics & Gynecology Science.2022; 65(5): 459. CrossRef Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer
Min Hui Park, Jung Eun Choi, Jae-Ryong Kim, Young Kyung Bae
Pathology and Oncology Research.2021;[Epub] CrossRef MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E. Krasniqi, A. Sacconi, D. Marinelli, L. Pizzuti, M. Mazzotta, D. Sergi, E. Capomolla, S. Donzelli, M. Carosi, A. Bagnato, T. Gamucci, S. Tomao, C. Natoli, P. Marchetti, A. Grassadonia, N. Tinari, M. De Tursi, E. Vizza, G. Ciliberto, L. Landi, F. Cappuzz
Biomarker Research.2021;[Epub] CrossRef
|